ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Selvita to Present New Data from its Oncology Programs at the Upcoming SITC 2018
November 10, 2018Data presented at the conference will include recent results from Selvita’s discovery phase project targeting cancer immunometabolism – a dual A2A/A2B adenosine receptor antagonist, as well as cancer immunotherapy – a novel class of small molecule direct
Pharma Sources Insight January 2025
